
The downgrade signals heightened risk for investors as Hyundai struggles to translate GST‑induced demand into sustainable volume growth, potentially reshaping competitive dynamics in India’s auto sector.
Hyundai Motor India’s latest earnings reveal a mixed picture: while EBITDA rose 8% year‑on‑year, the 17% quarter‑on‑quarter decline underscored lingering softness in domestic demand. The company attributes the shortfall to slower volume recovery despite GST‑driven price advantages and a dealer inventory that has improved to just under four weeks. Analysts note that the earnings miss widened the gap with both internal forecasts and Bloomberg consensus, prompting a reassessment of the firm’s near‑term profitability trajectory.
In response, Hyundai has taken several strategic steps. A price hike implemented on January 1 passed cost pressures to buyers, while new product launches and the commissioning of the Pune manufacturing plant aim to bolster the product mix. Export shipments continue to gain momentum, with expectations to outpace the earlier 7‑8% growth guidance. Nevertheless, the broker highlights a 1‑2% volume reduction and a 1‑3% EBITDA cut for FY26‑28, reflecting higher plant‑related costs and a cautious outlook on domestic sales recovery.
From an investment standpoint, InCred Equities trimmed the target price to ₹1,904, reduced the forward P/E multiple to 22×, and retained a Reduce rating. The adjustment reflects concerns over margin compression and the limited upside from GST‑induced demand tailwinds. For investors, the downgrade signals that Hyundai’s growth may lag peers unless volume recovery accelerates, making the stock a less attractive play amid an increasingly competitive Indian automotive landscape.
Comments
Want to join the conversation?
Loading comments...